| Literature DB >> 33563579 |
Ricardo D Parrondo1, Muhamad Alhaj Moustafa1, Craig Reeder2, Taimur Sher1, Vivek Roy1, Eli Muchtar3, Rahma Warsame3, Victoria Alegria1, Wilson Gonsalves3, David Dingli3, Suzanne Hayman3, Prashant Kapoor3, Asher A Chanan-Khan1, Sikander Ailawadhi4.
Abstract
Entities:
Keywords: Immunotherapy; Monoclonal antibodies; Multiple myeloma; Plasma cell dyscrasias; Targeted therapy
Mesh:
Substances:
Year: 2021 PMID: 33563579 DOI: 10.1016/j.clml.2021.01.002
Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN: 2152-2669